Skip to content

Kadimastem Ltd. vs ViaCyte

Kadimastem Ltd. logo

Kadimastem Ltd.

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments

32 employees · est. 2009 · Israel

VS
ViaCyte logo

ViaCyte

Regenerating Health: Transforming the lives of patients with insulin-requiring diabetes

35 employees · est. 1999 · San Diego, United States

ViaCyte is the older company (2009 vs 1999).

Side-by-Side Comparison

Kadimastem Ltd. ViaCyte
Founded
2009 1999 older
Headquarters
Israel San Diego, United States
Employees
32 35
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Grant Series D
Total Funding
$51.65M $235.55M
Funding Rounds
8 15
Taxonomy
BiotechStem Cell TherapyRegenerative MedicineNeurodegenerative DisordersCell ManufacturingDrug Screening +9 Regenerative MedicineCell TherapyDiabetes TreatmentStem Cell TherapyPancreatic Islet Progenitor CellsType 1 Diabetes +9
Website
kadimastem.com viacyte.com
Kadimastem Ltd. logo

About Kadimastem Ltd.

Kadimastem Ltd. is a clinical stage biotech company that has been disrupting the industry since its establishment in 2009. The company's slogan "A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments" embodies its commitment to leveraging...

ViaCyte logo

About ViaCyte

ViaCyte is a biotechnology startup from the United States, focused on developing revolutionary cell replacement therapies for long-term diabetes treatment, aiming to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications. ViaCyte's product candidates a...

Also comparing in this category

Comparing more than these two?

Get Kadimastem Ltd., ViaCyte and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Kadimastem Ltd. compare?

A PDF of Kadimastem Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Kadimastem Ltd. was founded in 2009, based in Israel, with 32 employees. Kadimastem Ltd. is a clinical stage biotech company that has been disrupting the industry since its establishment in 2009. The company's slogan "A clinical stage biotech company using PLATFORM TECH fo. ViaCyte was founded in 1999, based in San Diego, United States, with 35 employees. ViaCyte is a biotechnology startup from the United States, focused on developing revolutionary cell replacement therapies for long-term diabetes treatment, aiming to achieve glucose control targets an.
Kadimastem Ltd. has raised $51.65M and ViaCyte $235.55M. Latest stage: Kadimastem Ltd. Grant, ViaCyte Series D.
Both work in Biotechnology and Health and Wellness and list stem cell therapy, regenerative medicine and type 1 diabetes among their focus areas.

Compare Kadimastem Ltd. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Kadimastem Ltd. on 12 Sep 2024, and ViaCyte on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout